Professors Return to Labs to work on COVID-19 specific Research
Three UCI Pharmaceutical Sciences Faculty, Professors Andrej Luptak, John Chaput and Young Jik Kwon have been awarded COVID-19 Research awards by UCI to work on COVID-19 specific research. Their work offers the promise of major, and possibly immediate, impact on efforts to mitigate the spread of COVID19 and minimize the negative effects of the pandemic.
Diagnostics & Gene Silencing Therapeutics
Our research aims to create diagnostic agents that are rapid and simple to use. Similar to an over the counter pregnancy test, our assay will be nearly instantaneous and colorimetric, providing a straightforward way for healthcare workers to quickly identify and treat patients with COVID-19. In addition the Chaput lab will be working to create a novel class of drugs that would block the virus from recognizing a protein on the surface of a lung cell.
Young Jik Kwon
Nanoantiviral & Vaccine
The Kwon lab is creating a novel antiviral agent that can be inhaled and hinder the virus from growing and spreading. The are also working to develop an effective vaccine. They are also working to develop an effective vaccine.
Blocking and Detecting COVID-19
The Luptak lab is developing specialized, but easily produced, molecules that can block the virus from spreading within the lung tissue of a patient. Similarly, we are developing a diagnostic tool that would allow direct detection of the nCoV-2 virus in patient samples within minutes.
To learn more about these projects please contact us at firstname.lastname@example.org.